Cargando…
Light-responsive nanomedicine for cancer immunotherapy
Immunotherapy emerged as a paradigm shift in cancer treatments, which can effectively inhibit cancer progression by activating the immune system. Remarkable clinical outcomes have been achieved through recent advances in cancer immunotherapy, including checkpoint blockades, adoptive cellular therapy...
Autores principales: | Kang, Weirong, Liu, Yuwei, Wang, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326299/ https://www.ncbi.nlm.nih.gov/pubmed/37425044 http://dx.doi.org/10.1016/j.apsb.2023.05.016 |
Ejemplares similares
-
Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023) -
Nanomedicine for Combination Urologic Cancer Immunotherapy
por: Tian, Yun, et al.
Publicado: (2023) -
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021) -
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020) -
Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)